Taysha Gene Therapies, Inc.TSHA
Close of Friday, October 23, 2026 · Taysha Gene Therapies, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$3.96
vs its Pivot
-25.9%
OnlyAlpha Score
38
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot. ▲ closed at least 1% above the Pivot (in) · ▼ closed below it (out). Hover or drag across the chart for any day.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -17.3% | -28.0% | -19.8% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.09%IWM · 0.04%
Big investors that own it (latest 13F)
| RA Capital Peter Kolchinsky | 1.4% of holdings |
| OrbiMed Carl Gordon | 0.3% of holdings |
| Baker Bros. Advisors Julian and Felix Baker | 0.1% of holdings |
Get TSHA in your free daily emailAfter every close: whether TSHA is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track TSHA free → Full Stock check
Track TSHA free → Full Stock check